3 results
Approved WMOCompleted
1) To determine clinical safety and tolerability of local i.d. administration of a single dose of tremelimumab in clinical stage II melanoma patients scheduled to undergo a SLN procedure. 2) To ascertain the immunological effects of local i.d.…
Approved WMOCompleted
The aim of this study is to determine the feasibility to perform laparoscopic HIPEC in colorectal cancer patients at high risk of PC in a short stay setting.
Approved WMOCompleted
To determine the efficacy and safety of MEDI4736 evaluated as a single agent or in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) whose disease has progressed on 5-FU-containing or gemcitabine-…